Bronislaw Pytowski,Jonathan David Schwartz,Volker Wacheck,Sau-Chi Betty Yan
申请号：
US15122262
公开号：
US20160369004A1
申请日:
2015.02.25
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides preparation of medicaments for use in treating and methods of treating cancer selected from the group consisting of gastric cancer, HCC, and RCC comprising a C8-H241 Ab, preferably, C8-H241-IgG4, more preferably, emibetuzumab, in combination, as described herein, with an anti-VEGFR2 Ab, preferably, ramucirumab.
